Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens

Journal of Endocrinology

Volumn 191, Issue 3, 2006, Pages 613-624

  Fritah, Asmaà ^a   Redeuilh, Gérard ^a   Sabbah, Michèle ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ANTIESTROGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; GROWTH FACTOR; MESSENGER RNA; UNCLASSIFIED DRUG; WNT 1 INDUCED SIGNALLING PATHWAY PROTEIN 2;

5' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ESTROGEN RESPONSIVE ELEMENT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION SITE; UPREGULATION;

5' FLANKING REGION; BASE SEQUENCE; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; CLONING, MOLECULAR; CREB-BINDING PROTEIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TAMOXIFEN; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 33846820239     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.07009     Document Type: Article

References (44)

1. Banerjee S, Saxena N, Sengupta K, Tawfik O, Mayo MS & Banerjee SK 2003 WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation. Neoplasia 5 63-73.
2. Banerjee S, Sengupta K, Saxena NK, Dhar K & Banerjee SK 2005 Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks. Molecular Cancer Research 3 151-162.
3. Beato, M, Herrlich P & Schutz G 1995 Steroid hormone receptors: many actors in search of a plot. Cell 83 851-857.
4. Brigstock DR 1999 The connective tissue growth factor/cysteine-rich 61/ nephroblastoma overexpressed (CCN) family. Endocrine Reviews 20 189-206.
5. Brigstock DR 2003 The CCN family: a new stimulus package. Journal of Endocrinology 178 169-175.
6. Brigstock DR, Goldschmeding R, Katsube KI, Lam SC, Lau LF, Lyons K, Naus C, Perbal B, Riser B, Takigawa M et al. 2003 Proposal for a unified CCN nomenclature. Molecular Pathology 56 127-128.
7. Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ & Parker MG 1995 Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO Journal 14 3741-3751.
8. Chen D, Riedl T, Washbrook E, Pace PE, Coombes RC, Egly JM & Ali S 2000 Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Molecular Cell 6 127-137.
9. Chen D, Washbrook E, Sarwar N, Bates GJ, Pace PE, Thirunuvakkarasu V, Taylor J, Epstein RJ, Fuller-Pace FV, Egly JM et al. 2002 Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera. Oncogene 21 4921-4931.
10. Delaunay F, Pettersson K, Tujague M & Gustafsson JA 2000 Functional differences between the amino-terminal domains of estrogen receptors alpha and beta. Molecular Pharmacology 58 584-590.
11. Fan JD, Wagner BL & McDonnell DP 1996 Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Molecular Endocrinology 10 1605-1616.
12. Fritah A, Saucier C, Mester J, Redeuilh G & Sabbah M 2005 p21 WAF1 /CIP1 selectively controls the transcriptional activity of estrogen receptor alpha. Molecular and Cellular Biology 25 2419-2430.
13. Gronemeyer H 1991 Transcription activation by estrogen and progesterone receptors. Annual Review of Genetics 25 89-123.
14. Gruber CJ, Gruber DM, Gruber IM, Wieser F & Huber JC 2004 Anatomy ofthe estrogen response element. Trends in Endocrinology and Metabolism 15 73-78.
15. Harper JW & Elledge SJ 1996 Cdk inhibitors in development and cancer. Current Opinion in Genetics and Development 6 56-64.
16. Inadera H 2003 Estrogen-induced genes, WISP-2 and pS2, respond divergently to protein kinase pathway. Biochemical and Biophysical Research Communications 309 272-278.
17. Inadera H, Hashimoto S, Dong HY, Suzuki T, Nagai S, Yamashita T, Toyoda N & Matsushima K 2000 WISP-2 as a novel estrogen-responsive gene in human breast cancer cells. Biochemical and Biophysical Research Communications 275 108-114.
18. Inadera H, Dong HY & Matsushima K 2002 WISP-2 is a secreted protein and can be a marker of estrogen exposure in MCF-7 cells. Biochemical and Biophysical Research Communications 294 602-608.
19. Jacq X, Brou C, Lutz Y, Davidson I, Chambon P & Tom L 1994 Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79 107-117.
20. Javahery R, Khachi A, Lo K, Zenzie-Gregory B & Smale ST 1994 DNA sequence requirements for transcriptional initiator activity in mammalian cells. Molecular and Cellular Biology 14 116-127.
21. Kleer CG, Zhang Y, Pan Q, van Golen KL, Wu ZF, Livant D & Merajver SD 2002 WISP3 is a novel tumor suppressor gene of inflammatory breast cancer. Oncogene 21 3172-3180.
22. Klock G, Strahle U & Schutz G 1987 Oestrogen and glucocorticoid responsive elements are closely related but distinct. Nature 329 734-736.
23. Kumar V, Green S, Stack G, Berry M, Jin JR & Chambon P 1987 Functional domains ofthe human estrogen receptor. Cell 51 941-951.
24. Lake AC, Bialik A, Walsh K & Castellot JJ Jr 2003 CCN5 is a growth arrest-specific gene that regulates smooth muscle cell proliferation and motility. American Journal of Pathology 162 219-231.
25. Lo K & Smale ST 1996 Generality of a functional initiator consensus sequence. Gene 182 13-22.
26. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P et al. 1995 The nuclear receptor superfamily: the second decade. Cell 83 835-839.
27. Mason HR, Lake AC, Wubben JE, Nowak RA & Castellot JJ Jr 2004a The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells. Molecular Human Reproduction 10 181-187.
28. Mason HR, Grove-Strawser D, Rubin BS, Nowak RA & Castellot JJ Jr 2004b Estrogen induces CCN5 expression in the rat uterus in vivo. Endocrinology 145 976-982.
29. Ob YL, Choi JS, Song SY, Ko YH, Han BY, Nam SJ & Yang HH 2001 Expression of p21Waf1, p27Kip1 and cyclin D1 proteins in breast ductal carcinoma in situ: relation with clinicopathologic characteristics and with p53 expression and estrogen receptor status. Pathology International 51 94-99.
30. O'Lone R, Frith MC, Karlsson EK & Hansen U 2004 Genomic targets of nuclear estrogen receptors. Molecular Endocrinology 18 1859-1875.
31. Pennica D, Swanson TA, Welsh JW Roy MA, Lawrence DA, Lee J, Brush J, Taneyhill LA, Deuel B, Lew M et al. 1998 WISP genes are members ofthc connective time growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. PNAS 95 14717-14722.
32. Rachfal AW & Brigstock DR 2005 Structural and functional properties of CCN proteins. Vitamins and Hormones 70 69-103.
33. Redeuilh G, Attia A, Mester J & Sabbah M 2002 Transcriptional activation by the oestrogen receptor alpha is modulated through inhibition of cyclin-dependent kinases. Oncogene 21 5773-5782.
34. Reid G, Hubner MR, Metivier R, Brand H, Denger S, Mann D, Beaudouin J, Ellenberg J & Gannon F 2003 Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Molecular Cell 11 695-707.
35. Rosenfeld MG & Glass CK 2001 Coregulator codes of transcriptional regulation by nuclear receptors. Journal of Biological Chemistry 276 36865-36868.
36. Sabbah M, Gouilteux F, Sola B, Redeuilh G & Baulieu EE 1991 Structural differences between the hormone and antihormone estrogen receptor complexes bound to the hormone response element. PNAS 88 390-394.
37. Sabbah M, Radanyi C, Redeuilh G & Baulieu EE 1996 The 90 kDa heat-shock protein (hsp90) modulates the binding of the oestrogen receptor to its cognate DNA. Biochemical Journal 314 205-213.
38. Sabbah M, Kang KI, Tora L & Redeuilh G 1998 Oestrogen receptor facilitates the formation of preinitiation complex assembly: involvement of the general transcription factor TFIIB. Biochemical Journal 336 639-646.
39. Shang Y, Hu X, DiRenzo J, Lazar MA & Brown M 2000 Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103 843-852.
40. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A & Speleman F 2002 Accurate normalization of real-time quantitative RT-PCR data by geometric averaging ofinultiple internal control genes. Genome Biology 3 (RESEARCH0034).
41. Wood JR, Greene GL & Nardulli AM 1998 Estrogen response elements function as allosteric modulators of estrogen receptor conformation. Molecular and Cellular Biology 18 1927-1934.
42. Wu SY, Thomas MC, Hou SY, Likhite V & Chian CM 1999 Isolation of mouse TFIID and functional characterization of TBP and TFIID in mediating estrogen receptor and chromatin transcription. Journal of Biological Chemistry 274 23480-23490.
43. Zhang R, Averboukh L, Zhu W, Zhang H, Jo H, Dempsey PJ, Coffey RJ, Pardee AB & Liang P 1998 Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation. Molecular and Cellular Biology 18 6131-6141.
44. Zoubine MN, Banerjee S, Saxena NX, Campbell DR & Banerjee SK 2001 WISP-2: a senun-inducible gene differentially expressed in human normal breast epithelial cells and in MCF-7 breast tumor cells. Biochemical and Biophysical Research Communications 282 421-425.